The downregulation of mitoferrin-1 also slowed disease progression by altering mitochondrial iron metabolism and the production of reactive oxygen species in a C. elegans model of Alzheimer disease [69]. This evidence concerns the gene SLC25A37 and early-onset autosomal dominant Alzheimer disease.